Natalia Elizalde, Ph.D., Business Development Director
San Sebastian, Spain
VIVEbiotech is a GMP CDMO fully focused on the development and GMP manufacture of lentiviral vectors. VIVEbiotech is currently working for customers based in Europe, the U.S., and Asia, manufacturing lentiviral vectors for different applications such as rare diseases and onco-cell therapy (CAR-Ts, TCRs, CAR-NKs, TILs), among others. One of VIVEbiotech´s main features is our specialization in virology. Based on it, the R&D department is focusing its efforts on the development of more cost-effective processes and safer lentiviral vectors (worldwide patented technology called Lentisoma). VIVEbiotech is now immersed in an expansion plan that will soon allow commercial scale manufacturing of lentiviral vectors.

By using this website you agree to accept our Privacy Policy and Terms & Conditions